Darbepoetin alfa is a synthetic erythropoiesis-stimulating agent used to treat anemia in chronic kidney disease and cancer patients. It works by stimulating red blood cell production in the bone marrow. Darbepoetin alfa is effective for managing anemia and reducing the need for blood transfusions. In summary, it is crucial for improving hemoglobin levels in affected patients.
Darbepoetin alfa stimulates erythropoietin receptors in the bone marrow, promoting red blood cell production.